School of Medicine
UConn Magazine: First-Years
Three UConn School of Medicine graduates take us through year one of residency —with its fast-and-furious rotations meant to teach the finer points of chosen specialties and the broad realities of what it means to be a practicing doctor
UConn Expert Member of Global Commission Calling on World to Improve Sickle Cell Disease Care
Global mortality from sickle cell disease may be nearly 11 times higher than recorded, says new Commission of world experts published in The Lancet Haematology journal.
Federal Funding Renewed for UConn’s Cross-Campus Center of Excellence in Developmental Disabilities Education, Research and Service
UConn's UCEDD is on the front lines in Connecticut helping those with disabilities and their families and building the capacity of the future workforce to conduct research and deliver evidence-based intervention practices.
Remembering Dr. Naomi F. Rothfield
As one of UConn School of Medicine’s first women faculty, legendary internationally-renowned rheumatologist Dr. Naomi Rothfield had a nearly 50 year career at UConn Health retiring in 2016. She passed away on Sunday, July 2.
Patient Group Honors Dr. Peter Albertsen as Pioneer in Prostate Cancer Management
Chief and program director of UConn Health’s Division of Urology was an early advocate of active surveillance, originally an unpopular alternative to surgery and radiation in low-grade cancers
Dr. Cato T. Laurencin Elected to the Council of the National Academy of Medicine
This July Dr. Laurencin begins his 3-year term for the Academy’s governing and oversight body.
Jonathan XV has Arrived, and Doggone it, He’s Adorable
UConn Nation got a doggone great surprise on Wednesday with the introduction of mascot-in-training Jonathan XV
Shorter Telomeres Point to Increased Alzheimer’s Risk
If longer telomeres actually reduce Alzheimer's risk, it’s one more reason for people to adopt a healthy lifestyle
Innovation at UConn Health: Meet Basic Scientist Kimberly Dodge-Kafka, Ph.D.
“My big hope is to develop a new type of beta-blocker drug for humans that can block or reverse heart disease progression so patients can live a better, fuller, and longer life,” says Dodge-Kafka, a recent recipient of a large multimillion dollar NIH grant to grow her novel cardiac cell signaling research.
Podcast: Managing Movement Disorders Like Parkinson’s Disease
Early diagnosis and intervention plus supportive care and planning can significantly improve quality of life for those with Parkinson's disease and their families